Skip to content

NUPHAR TECH: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

NUPHAR TECH

BE 0700.488.270
NACE 72.101, Research and development on biotechnology
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€12,121
2024 · -€13,561+€1,440
Equity
-€216,475
2024 · -€204,355-€12,121
Cash
€3,771
2024 · €6,545-€2,774
Balance sheet total
€20,308
2024 · €20,968-€661

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€7,113

    up €7,113 (+78.9%), from €9,018 to €16,132

    of which Trade receivables: +€7,111

  • Stocks and contracts -€5,000

    down €5,000 (-100.0%), from €5,000 to €0

  • Cash -€2,774

    down €2,774 (-42.4%), from €6,545 to €3,771

    mainly Net result for the year (-€12,121) and Receivables within one year (-€7,113)

Equity and liabilities
  • Profit (loss) carried forward -€12,121

    down €12,121 (-4.3%), from -€284,355 to -€296,475

  • Trade debts +€5,228

    up €5,228 (+1302.2%), from €401 to €5,629

  • Other debts +€4,000

    up €4,000 (+1.8%), from €223,939 to €227,939

  • Advances received +€3,215

    new in 2025: €3,215

  • Tax, wage and social debts -€982

    down €982 (-100.0%), from €982 to €0

Income statement
  • Write-downs -€41,200

    down €41,200, from €0 to -€41,200

  • Gross operating margin -€40,256

    down €40,256 (-313.8%), from -€12,829 to -€53,085

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€13,561
Gross operating margin -€40,256
Write-downs +€41,200
Other operating charges +€16
Financial income +€91
Financial charges +€389
Result 2025 -€12,121

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€2,774
Investment €0
Financing €0
Cash 2024 €6,545
Net result for the year -€12,121
Stocks and contracts +€5,000
Receivables within one year -€7,113
Trade debts +€5,228
Tax, wage and social debts -€982
Advances received +€3,215
Other debts +€4,000
Cash 2025 €3,771
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €20,968 €20,308 -€661 -3.2%
Current assets 29/58 €20,968 €20,308 -€661 -3.2%
Stocks and contracts in progress 3 €5,000 €0 -€5,000 -100.0%
Stocks 30/36 €5,000 €0 -€5,000 -100.0%
Amounts receivable within one year 40/41 €9,018 €16,132 +€7,113 +78.9%
Trade receivables 40 €3,744 €10,855 +€7,111 +189.9%
Other amounts receivable 41 €5,275 €5,277 +€2 0.0%
Cash at bank and in hand 54/58 €6,545 €3,771 -€2,774 -42.4%
Deferred charges and accrued income 490/1 €405 €405 = 0.0%
Total equity and liabilities 10/49 €20,968 €20,308 -€661 -3.2%
Equity 10/15 -€204,355 -€216,475 -€12,121 -5.9%
Contributions 10/11 €80,000 €80,000 = 0.0%
Profit (loss) carried forward 14 -€284,355 -€296,475 -€12,121 -4.3%
Amounts payable 17/49 €225,323 €236,783 +€11,460 +5.1%
Amounts payable after more than one year 17 €0 - =
Financial debts 170/4 €0 - =
Amounts payable within one year 42/48 €225,323 €236,783 +€11,460 +5.1%
Trade debts 44 €401 €5,629 +€5,228 +1302.2%
Suppliers 440/4 €401 €5,629 +€5,228 +1302.2%
Advances received on contracts in progress 46 - €3,215 +€3,215
Taxes, remuneration and social security 45 €982 €0 -€982 -100.0%
Taxes 450/3 €982 €0 -€982 -100.0%
Other amounts payable 47/48 €223,939 €227,939 +€4,000 +1.8%
Accrued charges and deferred income 492/3 €0 - =
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €0 - =
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €0 -€41,200 -€41,200
Other operating charges 640/8 €206 €190 -€16 -7.8%
Gross operating margin 9900 -€12,829 -€53,085 -€40,256 -313.8%
Operating profit (loss) 9901 -€13,035 -€12,075 +€960 +7.4%
Financial income 75/76B €0 €91 +€91
Recurring financial income 75 €0 €91 +€91
Financial charges 65/66B €526 €137 -€389 -73.9%
Recurring financial charges 65 €526 €137 -€389 -73.9%
Profit (loss) for the period before taxes 9903 -€13,561 -€12,121 +€1,440 +10.6%
Profit (loss) for the period 9904 -€13,561 -€12,121 +€1,440 +10.6%
Profit (loss) for the period to be appropriated 9905 -€13,561 -€12,121 +€1,440 +10.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.